Compare · HUM vs MTAC
HUM vs MTAC
Side-by-side comparison of Humana Inc. (HUM) and MedTech Acquisition Corporation (MTAC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HUM and MTAC operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM is the larger of the two at $25.96B, about 84.1x MTAC ($308.8M).
- HUM has hit the wire 13 times in the past 4 weeks while MTAC has been quiet.
- HUM has more recent analyst coverage (25 ratings vs 0 for MTAC).
- Company
- Humana Inc.
- MedTech Acquisition Corporation
- Price
- $215.14+0.15%
- $11.67+15.43%
- Market cap
- $25.96B
- $308.8M
- 1M return
- +23.51%
- -
- 1Y return
- -18.25%
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 13
- 0
- Recent ratings
- 25
- 0
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
MedTech Acquisition Corporation
MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Latest HUM
- SEC Form 3 filed by new insider Field Robert Stuart
- Humana Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- CenterWell Introduces the Fulfillment Index, a New Measure of What It Means to Age Well
- SEC Form S-8 filed by Humana Inc.
- Humana Board Declares Payment of Quarterly Dividend to Stockholders
- On the Line for Lung Health: Telephone Training Helps COPD Patients Perfect Inhaler Use
- Tuesday Health Expands National Footprint With Humana Partnership to Advance Value-Based Palliative Care
- Humana Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Humana Elects Robert S. Field to Board of Directors
- Humana Goes Live with b.well to Deliver on Health Data Interoperability Commitments
Latest MTAC
- Szela Mary T was granted 84,899 shares, increasing direct ownership by 30% to 364,862 units (SEC Form 4)
- Marshak Richard was granted 14,752 shares, increasing direct ownership by 118% to 27,251 units (SEC Form 4)
- Cox Bryan F. was granted 14,752 shares, increasing direct ownership by 21% to 86,696 units (SEC Form 4)
- Stevens Jennifer was granted 14,752 shares, increasing direct ownership by 82% to 32,783 units (SEC Form 4)
- Devlin Jodi was granted 17,500 shares (SEC Form 4)
- Murphy Sean was granted 34,144 shares, increasing direct ownership by 205% to 50,788 units (SEC Form 4)
- Katz Steven C was granted 34,144 shares, increasing direct ownership by 99% to 68,587 units (SEC Form 4)
- SEC Form 4 filed by Murphy Sean
- SEC Form 4 filed by Marshak Richard
- SEC Form 424B3 filed by MedTech Acquisition Corporation